Keywords: schering-plough, sees, 2nd-qtr, income, 0m, sales, rise
Schering-Plough sees 2nd-qtr income of $237.0M as sales rise 11% to $2.8 billion
Article | 31 July 2006
New Jersey, USA-based pharmaceutical firm Schering-Plough says that its 2006 second quarter income was $237.0 million, or $0.16 per share, on a Generally-Accepted ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
